Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Hedhliabir (Ariana, Tunisia), A. Slim (Ariana, Tunisia), S. Cheikh Rouhou (Ariana, Tunisia), S. Ben Khaled (Ariana, Tunisia), A. Taboubi (Ariana, Tunisia), Y. Ouahchi (Ariana, Tunisia), J. Cherif (Ariana, Tunisia), S. Toujani (Ariana, Tunisia), M. Mjid (Ariana, Tunisia), S. Merai (Ariana, Tunisia). Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease. 1072

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Platelets count in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations Source: International Congress 2017 – COPD and weaning Year: 2017 The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Polymorphonuclear elastasa and collagenasa activity in patients with chronic obstructive pulmonary disease and acute bronchities Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Platelet aggregability at night in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 98s Year: 2002 Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19 Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 288s Year: 2006 Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001 Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD. Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017